Oxidative damage to DNA occurs with cell proliferation and increases with age. Certain organs such as the gut are heavily exposed to oxidising agents, which impacts on carcinogenic potential. Dysfunction of base excision repair, the major pathway for repairing oxidative damage, has been implicated as a risk factor for the development of multiple colorectal adenomas and colorectal cancer (CRC; [@bib1]; [@bib7]; [@bib10]). Bi-allelic mutations of the *MUTYH* gene seem to be responsible for a high proportion of the multiple adenoma phenotype families (termed *MUTYH*-associated polyposis (MAP)) unaccounted for by germline *APC* mutations ([@bib1]; [@bib23]; [@bib24]; [@bib13]; [@bib27]; [@bib20]) and predispose to CRC *per se* ([@bib9]; [@bib7]; [@bib12]; [@bib16]; [@bib28]; [@bib10]; [@bib22]; [@bib30]; [@bib19]; [@bib25]; [@bib29]; [@bib17]; [@bib5]; [@bib18]). Although an increased CRC risk associated with bi-allelic *MUTYH* mutations is incontrovertible, the risk associated with one *MUTYH* mutant allele is controversial ([@bib7]; [@bib10]; [@bib14]; [@bib25]; [@bib29]; [@bib5]; [@bib15]; [@bib18]). A statistically significant or close to significant effect, for a *MUTYH* mono-allelic effect, has been reported in different studies with possible age specific effects present, but the rarity of the alleles associated with the small increased risk for CRC have made it difficult to replicate study findings. A recent risk analysis of MAP family members agreed with previous family based findings ([@bib14]) that mono-allelic carriers are at a two-fold increase in risk of CRC ([@bib15]) providing further evidence of a mono-allelic effect of the gene. However, family based studies can be subject to ascertainment bias and any mono-allelic effect could potentially be modified by other inherited factors, including alleles at other loci. Furthermore, environmental risk factors also show familial aggregation and hence, studies in which there has been selection of cases based on family history may be confounded. Bi-allelic carriers may develop CRC because of the predominant effect of *MUTYH*, whereas the environmental effect is greater in affected siblings with mono-allelic mutations but the risk is ascribed to the *MUTYH* allele. Thus further work is required to resolve the mono-allelic carrier risk question.

To clarify the role of *MUTYH* in disease risk, we initiated a multi-centre collaboration allowing large-scale meta-analysis of the individual *MUTYH* variants, with special interest in determining if there were age and sex-specific effects on CRC association with *MUTYH* variants ([@bib11]). In this study, we present the results of this collaborative meta-analysis.

Subjects and methods
====================

Participating studies
---------------------

Relevant case--control studies to be invited for inclusion in the meta-analysis of the effect of *MUTYH* on CRC risk were identified by a literature search in the ISI Web of Science (<http://wok.mimas.ac.uk>) and PUBMED bibliographic databases (<http://www.ncbi.nlm.nih.gov/pubmed/>), using the search terms 'MYH or *MUTYH* and CRC\'. In the initial search 55 studies were identified and eight of these were considered for our study ([@bib9]; [@bib7]; [@bib12]; [@bib16]; [@bib28]; [@bib10]; [@bib22]; [@bib30]). The inclusion criteria were as follows: the patients had to be diagnosed with CRC and the studies had to have genotype data for both cases and controls. Ten additional studies were identified during the progress of the project -- [@bib29], [@bib19], [@bib17], [@bib5], [@bib18]; and unpublished data from Koessler T and Pharoah PD; and Tomlinson -- personal communication. [@bib6]; [@bib3]; [@bib2] were used in the pooled meta-analysis of all available published and unpublished datasets.

The principal investigators (PIs) of the selected studies were contacted and were asked to participate by providing a minimum dataset including variables necessary for the analysis (Supplementary Box 1: Study questionnaire; Supplementary Table 1: Data extraction table). In cases, in whom PIs failed to respond to our invitation to participate, reminder letters were despatched. It was not possible to include data from the following studies in the logistic regression analyses because (i) data was only available for cases that were heterozygous or homozygous for a *MUTYH* mutation ([@bib9]); (ii) co-variate data were only available for cases, as controls were anonymous blood donors ([@bib30]; Tomlinson, unpublished data); (iii) failure to communicate with us ([@bib16] and [@bib28]). The study by [@bib12] and [@bib29] were not used because they had been superseded by a later study ([@bib18]), which was included.

Statistical analysis
--------------------

Data from all collaborating centres were checked for completeness, coded and merged to form a core database. *MUTYH* defects were considered pathogenic only if there was published evidence of their pathogenicity. Individuals reported to have two defects of *MUTYH* in the original report were classified as mutated/mutated (MM), those with one defect as wild type/mutant (WM) and those with no mutation as wild type/wild type (WW). Descriptive statistics were produced on all subject characteristics, risk factors and event data. All populations described in the case--control studies were tested for Hardy--Weinberg equilibrium in controls and the genotype distributions between all groups were compared by *χ*^2^-test.

Three logistic regression models were applied to address confounding co-variates (model I: crude, model II: including co-variates for age and sex, model III: including co-variates for age, sex and study) on the combined datasets investigating the effect of *MUTYH* defects (WM *vs* WW and MM *vs* WW) as well as of the individual mutations Y179C (c.536A\>G/p.Tyr179Cys; AA=WW, GG=MM) and G396D (c.1187G\>A/p.Gly396Asp; GG=WW, AA=MM; previously known as Y165C and G382D), to identify any variant specific associations. The three logistic regression models were applied after sex and age (over 55 years and under or equal 55 years) stratification as previously described ([@bib10]), to assess the effect of age and sex on the association of the variants with disease risk. In all the studies, interaction associations between the *MUTYH* variants and study code (for each individual study) were estimated and similarly between *MUTYH* variants and hormone replacement therapy (HRT) among female participants in three studies (the Scottish SOCCS studies and the studies -- [@bib7]; [@bib5]). Association between both genetic (i.e., one of the *MUTYH* mutations) and the study code or environmental factor (i.e., HRT) and disease was assessed and interaction was tested by fitting interactive and nested multiplicative models. To assess for any small study effects, we performed Funnel plot analysis and tested for significance using the Harbord test.

Finally, the relationship between the genotype and CRC was analysed by meta-analysis, combining the effect estimates of all published and unpublished datasets.

All statistic analyses were conducted using Intercooled STATA version 10.0 (Stata Corp, College Station, TX, USA). For the logistic regression analyses, it is necessary to add a whole number to any fields containing 0 (see model I^a^ in Table 2), which reduces the final OR value, however, by using the META command in the STATA meta-analysis programme, a lower value can be added (0.5 as indicated by model I^b^ in Table 2) thereby giving a more accurate assessment of risk. However, this is a grouped analysis and therefore cannot be adjusted for confounding co-variates, such as age/sex and study as in models II and III. To account for multiple testing we applied the Bonferroni correction method, and the *P*-value threshold for significance was estimated to be 0.003.

Results
=======

[Table 1](#tbl1){ref-type="table"} details summary data from the studies included in our combined analysis (comprising a total of 20 565 cases and 15 524 controls). The two variant alleles are rare with G396D variant allele having a frequency of 0.007 in controls and the Y179C variant allele a frequency of 0.002. Tests for deviation from Hardy--Weinberg equilibrium in controls were *P*=0.99 and *P*\<0.00005 for G396D and Y179C variants, respectively.

Bi-allelic effect of *MUTYH*
----------------------------

All three models of the logistic regression analysis gave consistent results and so the results of the crude analysis (model I) are described below and presented in [Table 2](#tbl2){ref-type="table"}; results of the other two models can be found in Supplementary Table 2. Bi-allelic carriers for the MM genotype of the combined *MUTYH* defects, G396D and Y179C/G396D compound heterozygotes were associated with a significant increase in CRC risk (odds ratio (OR)=28.3, 95% confidence limits (CIs): 6.95--115; 23.1 (95% CI: 3.15--169) and 21.6 (95% CI: 2.94--159), respectively). These risks are conservative, concentrating on the significant logistic regression results -- model I^b^ results presented in [Table 2](#tbl2){ref-type="table"} are likely a better reflection of risk and tend to be two-fold higher. There was a greater CRC risk for the MM genotype for the earlier age individuals when compared with the older age group (OR=36.2 (95% CI: 4.98--263) for ⩽55 years compared with 11.6 (95% CI: 2.77--48.2) for \>55 years). However, their CIs overlapped and the results were not statistically significantly different. ANOVA analysis of mean age of carriers demonstrated that there are significant age differences between cases and controls when considering MM genotype carriers and Y179C bi-allelic carriers but not for G396D carriers (*P*\<0.0005, *P*\<0.0005 and *P*=0.27, respectively -- Supplementary Table 3). Indeed there is a significant age difference between mean age of bi-allelic Y179C and G396D carriers (48.9 *vs* 56.7, respectively, *P*=0.003 based on *t*-test -- Supplementary Table 4).

Colorectal cancer risk associated with mono-allelic *MUTYH* mutations
---------------------------------------------------------------------

The results of the combined analysis demonstrate that there are no significant mono-allelic effects for either G396D or for combined *MUTYH* variants ([Table 2](#tbl2){ref-type="table"}). However, the specific Y179C variant was shown to increase risk of disease in the heterozygous state (OR=1.34; (95% CI: 1.00--1.80)) in the whole sample set and also when stratified by sex, male sex demonstrated a mono-allelic effect (OR=1.70; (95% CI: 1.06--2.73)). However, after Bonferroni correction, these mono-allelic effects did not remain significant.

The role of study population and HRT in modulating CRC risk
-----------------------------------------------------------

We hypothesised that origin of the data, that is, study population might modify the association between the genotype and CRC risk. However, there was no evidence for an interaction between study code and *MUTYH* genotypes (Supplementary Table 5). Similarly, HRT intake, a known risk factor for CRC ([@bib4]; [@bib26]), might be influenced by genotype and therefore modulate female risk. Both the Scottish and Canadian datasets had recorded data on HRT intake and these were used to test for an interaction between HRT and *MUTYH* genotype. Across both datasets there was no evidence of any interaction between HRT and *MUTYH* genotype (Supplementary Table 6).

Meta-analysis of published and unpublished datasets
---------------------------------------------------

The results of a meta-analysis of published and unpublished datasets submitted to us, estimating the effect of the *MUTYH* whole gene defects demonstrated a pooled fixed bi-allelic effect of 10.8 (95% CI: 5.02--23.2) for the MM and a pooled fixed mono-allelic effect of 1.16 (95% CI: 1.00--1.34) for WM genotype ([Table 3](#tbl3){ref-type="table"}; [Figures 1](#fig1){ref-type="fig"} and [2](#fig2){ref-type="fig"}). Analysis of the specific variants by pooled meta-analysis demonstrated bi-allelic effects for both G396D and Y179C (OR=6.47 (95% CI: 2.33--18.0) and OR=3.35 (95% CI: 1.14--9.89), respectively) and in agreement with the logistic regression analysis results, Y179C variant also demonstrated a very similar pooled fixed mono-allelic effect of 1.34 (95% CI: 1.01--1.77; [Tables 4](#tbl4){ref-type="table"} and [5](#tbl5){ref-type="table"}; Supplementary Figures 1--4).

Assessment of study publication bias
------------------------------------

Funnel plots for both the mono- and bi-allelic effect were created to assess whether study size was significantly influencing the results. These plots appeared asymmetric, but the Harbord\'s test for small study effect demonstrated that this was not statistically significant (Supplementary Figures 5 and 6).

Discussion
==========

This large meta-analysis study refines the estimates of CRC risk associated with mutations in the *MUTYH* gene to date. Bi-allelic carriers of the combined *MUTYH* mutations (MM) are associated with a 28-fold (95% CI: 6.95--115) increase in CRC risk from the logistic regression analysis. Bi-allelic carriers of the G396D variant and Y179C/G396D compound heterozygotes were also significantly associated with a similar increase in CRC risk (OR=23.1 (95% CI: 3.15--169) and 21.6 (95% CI: 2.94--159), respectively). Although the risk estimate was slightly lower from the overall larger pooled meta-analysis of published and unpublished datasets (OR=10.8 (95% CI: 5.02--23.2)), both G396D and Y179C variants demonstrated bi-allelic effects in this pooled analysis (OR=6.47 (95% CI: 2.33--18.0) and OR=3.35 (95% CI: 1.14--9.89), respectively). A marginal significant mono-allelic effect was demonstrated for the specific variant Y179C (OR=1.34 (95% CI: 1.00--1.80)) and indeed a marginally significant result was also observed in the pooled meta-analysis for *MUTYH* WM (OR=1.16 (95% CI: 1.00--1.34)) and Y179C variant alone, 1.34 (95% CI: 1.01--1.77). The increased bi-allelic risk of CRC varied when stratified for age and sex but none of the differences were significant, although when stratified by sex, males showed a marginal significant mono-allelic effect for Y179C (OR=1.70; 95% CI: 1.06--2.73). The results from this large dataset indicate that the two variants may be acting mechanistically differently; G396D appears to be a true example of recessive Mendelian disease, whereas the results for Y179C are more complex and there is therefore some argument against combining the two variants. However, the results from the Y179C/G396D compound heterozygotes analysis demonstrates an increase in risk similar to G396D bi-allelic carriers, suggesting that the two variants are complementary and analysis of combined *MUTYH* mutations as historically performed, appears appropriate to assess risk for the whole gene. The rarity of the Y179C allele has made it difficult to truly assess its effect on disease risk, however the large numbers analysed in this report have resulted in the demonstration that both bi-allelic and mono-allelic Y179C variants are associated with disease risk.

The study population did not appear to modulate disease risk and although the study replicated the reported decrease in disease risk in *MUTYH* wild-type females associated with HRT intake ([@bib4]; [@bib26]), we found no interaction with the *MUTYH* gene and its variants. Therefore, it is unlikely that HRT intake is an explanation for any sex variation in risk and other genetic factors may be involved in modifying CRC risk.

Evidence of a mono-allelic *MUTYH* effect on CRC has been reported in several case--control studies ([@bib7]; [@bib28]; [@bib10]; [@bib30]; [@bib25]; [@bib5]) and family-based studies ([@bib14]; [@bib15]), but not in other studies ([@bib16]; [@bib29]; [@bib3]; [@bib18]). Our large meta-analysis has demonstrated a marginal significant association for the specific variant Y179C, highlighting the possible increased phenotypic severity of this allele. This is in agreement with other studies and biochemical and model organism studies, which indicate that this variant shows an increased detrimental effect on protein function ([@bib1]; [@bib21]; [@bib18]; [@bib20]; [@bib8]). The pooled analysis of published studies and unpublished datasets submitted to us also indicated a marginally significant mono-allelic *MUTYH* effect, as well as a mono-allelic Y179C effect.

However, there are a number of caveats that need to be considered; if any of the studied datasets contain cases recruited because of the familial clustering of disease, there may be ascertainment bias, artificially inflating the number of *MUTYH* WM variant allele carriers; secondly the screening of the *MUTYH* gene has predominantly been performed on the two most common pathogenic variants Y179C and G396D -- in some studies, the rest of the gene may be explored in cases with a heterozygous allele for these variants but not usually in the controls, hence there is an overall screening bias and bi-allelic carriers may well have been missed in both cases and controls.

The demonstration of a mono-allelic effect specifically for Y179C should be considered with further caution, as analysis of the control datasets for the Y179C allele demonstrated that it was not in Hardy--Weinberg equilibrium. This may be because of several factors, the rarity of the allele and the fact that both female control subjects with bi-allelic mutations carry Y179C variants. One of these control subjects was shown to have polyps on colonoscopy ([@bib5]) and may therefore be considered a case. The other is relatively young, less than 60 years old ([@bib18]), so potentially may develop cancer over the next few years. However, in this large dataset, we have also shown that bi-allelic carriers of Y179C predisposes to an earlier onset of disease than G396D, consistent with previous reports ([@bib18]; [@bib20]) and highlights a severer disease phenotype of this variant.

In conclusion, inactivation of the *MUTYH* gene is a recessive risk factor for CRC, with possible modifying effects indicated by increased risk in cases with early age of onset, although not significantly different in the current dataset. An increased risk associated with mono-allelic *MUTYH* mutation is indicated, albeit small and not currently clinically relevant, and likely specific for the variant Y179C. Despite the size of this study it has not been possible to definitively establish whether there are significant age and sex effects of increasing disease risk for G396D and Y179C carriers. The evidence presented raises the possibility of a mono-allelic effect for Y179C, but the effect is low (OR 1.34; 95% CI: 1.00--1.80) and is sensitive to variations in population allele frequency because of the rarity of the variant (allele frequency 0.002), as well as potential issues of subgroup analysis and multiple testing (indeed the overall significance is lost after Bonferoni correction). Nonetheless, it does appear that this study is the first to demonstrate that the Y179C variant does impart an increased risk of CRC.
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###### 

Click here for additional data file.

![Meta-analysis of studies comparing *MUTYH* MM *vs* WW. SOCCS data include [@bib10], [@bib25]) and unpublished data from the SOCCS study obtained in 2008; Cleary data include [@bib7]; Lubbe data include [@bib29] and [@bib12]. Unpublished studies included are Tomilson I (2006) and Koessler T (2007).](6605966f1){#fig1}

![Meta-analysis of studies comparing *MUTYH* WM *vs* WW. SOCCS data include [@bib10], [@bib25] and unpublished data from the SOCCS study obtained in 2008; Cleary data include [@bib7]; Lubbe data include [@bib29] and [@bib12]. Unpublished studies included are Tomilson I (2006) and Koessler T (2007).](6605966f2){#fig2}

###### Summary table[a](#t1-fn2){ref-type="fn"}

                                                                                                     **G396D**   **Y179C**   **Genotype**   **Age**   **Sex**   **Ethnicity**                                                                                                   
  ----------------------------------------------------------------------------------------- -------- ----------- ----------- -------------- --------- --------- --------------- -------- ----- ---- --------------- ------------- --------------- --------------- ------------- ------------------------------------
  All studies                                                                                                                                                                                                                                                                   
   *Cases*                                                                                  20 565   19 966      324         33             20 260    154       11              19 783   417   76   20 555 (99.9)   59.5 (10.1)   20 555 (99.9)   11 668 (56.8)   5374 (26.1)   5030 (93.6)
   *Controls*                                                                               15 524   15 145      211         0              15 074    68        2               14 723   280   2    15 287 (98.5)   59.0 (10.9)   15 521 (99.9)   6845 (44.1)     5597 (36.1)   4796 (85.7)
                                                                                                                                                                                                                                                                                
  [@bib7]                                                                                                                                                                                                                                                                       
   *Cases*                                                                                  1238     1209        25          4              1223      13        2               1197     29    12   1236 (99.8)     60.1 (8.7)    1236 (99.8)     544 (44.0)      Missing       Missing
   *Controls*                                                                               1255     1238        17          0              1251      4         0               1234     21    0    1244 (99.1)     63.6 (8.6)    1252 (99.8)     702 (56.1)      Missing       Missing
                                                                                                                                                                                                                                                                                
  [@bib22]                                                                                                                                                                                                                                                                      
   *Cases*                                                                                  585      567         3           1              569       3         0               552      4     2    584 (99.8)      62.1 (13.1)   584 (99.8)      319 (54.6)      585 (100)     251 (42.9)
   *Controls*                                                                               1158     1040        5           0              1039      2         0               923      7     0    1148 (99.1)     53.9 (11.5)   1156 (99.8)     240 (20.8)      1158 (100)    363 (31.3)
                                                                                                                                                                                                                                                                                
  SOCCS (includes data from [@bib10], [@bib25] and unpublished SOCCS prospective samples)                                                                                                                                                                                       
   *Cases*                                                                                  3278     3086        55          8              3192      23        0               3038     71    12   3277 (100)      59.5 (11.3)   3278 (100)      1883 (57.4)     3278 (100)    3268 (99.7)
   *Controls*                                                                               3318     3239        43          0              3061      15        0               2993     57    0    3313 (99.8)     61.4 (10.9)   3318 (100)      1861 (56.1)     3318 (100)    3312 (99.8)
                                                                                                                                                                                                                                                                                
  [@bib19]                                                                                                                                                                                                                                                                      
   *Cases*                                                                                  356      343         8           1              348       0         0               336      8     1    356 (100)       66.5 (11.7)   356 (100)       217 (61.0)      Missing       Missing
   *Controls*                                                                               297      285         7           0              291       0         0               283      7     0    297 (100)       65.3 (12.5)   297 (100)       158 (53.2)      Missing       Missing
                                                                                                                                                                                                                                                                                
  Koessler T, (unpublished data obtained in 2007)                                                                                                                                                                                                                               
   *Cases*                                                                                  2262     2215        31          2              2227      19        1               2198     37    9    2253 (99.6)     59.1 (8.1)    2262 (100)      1287 (57.1)     Missing       Missing
   *Controls*                                                                               2253     2217        31          0              2236      11        0               2204     42    0    2053 (91.1)     53.4 (7.6)    2253 (100)      949 (42.0)      Missing       Missing
                                                                                                                                                                                                                                                                                
  [@bib17]                                                                                                                                                                                                                                                                      
   *Cases*                                                                                  1025     1003        22          0              1021      4         0               999      25    1    1023 (99.8)     68.7 (9.9)    1025 (100)      632 (61.7)      1025 (100)    1025 (100)
   *Controls*                                                                               1121     1105        16          0              1117      4         0               1100     21    0    1121 (100)      61.9 (10.0)   1121 (100)      609 (54.3)      1121 (100)    1121 (100)
                                                                                                                                                                                                                                                                                
  SOCCS retrospective cases (unpublished data obtained in 2008)                                                                                                                                                                                                                 
   *Cases*                                                                                  486      403         6           2              446       2         3               391      6     4    486 (100)       54.7 (17.2)   479 (98.6)      240 (50.1)      486 (100)     486 (100)
   *Controls*                                                                               0        0           0           0              0         0         0               0        0     0    0                             0                               0              
                                                                                                                                                                                                                                                                                
  [@bib5]                                                                                                                                                                                                                                                                       
   *Cases*                                                                                  2076     2023        33          5              2053      7         1               2029     38    9    2070 (99.7)     56.6 (10.8)   2076 (100)      1114 (53.7)     Missing       Missing
   *Controls*                                                                               1049     1032        17          0              1042      6         1               1024     24    1    1047 (99.8)     56.4 (11.3)   1049 (100)      444 (42.3)      Missing       Missing
                                                                                                                                                                                                                                                                                
  [@bib18][b](#t1-fn3){ref-type="fn"}                                                                                                                                                                                                                                           
   *Cases*                                                                                  9268     9117        141         10             9181      83        4               9043     198   27   9268 (100)      59.0 (8.5)    9268 (100)      5432 (58.6)     Missing       Missing[c](#t1-fn4){ref-type="fn"}
   *Controls*                                                                               5064     4989        75          0              5037      26        1               4962     101   1    5064 (100)      59.2 (10.8)   5064 (100)      1882 (37.2)     Missing       Missing[c](#t1-fn4){ref-type="fn"}

Abbreviations: MM=mutated/mutated; WM=wild type/mutant; WW=wild type/wild type.

This table presents the raw data sent to us by each group that was then included in the analyses. G396D and Y179C are looked at independently and any compound bi-allelic carriers are presented as heterozygotes for each variant; MUTYH genotype data also includes other pathogenic mutations; unpublished data are included in Peterlonogo P and Moreno V, SOCCS prospective and Küry S.

Includes data from [@bib29] and [@bib12].

All the cases and controls were UK residents and of European ancestry (self-reported).

###### Logistic regression analysis of the combined datasets; G396D analysis was conducted for individuals that were Y179C AA; Y179C analysis was conducted for individuals that were G396D GG; combined genotype analysis was conducted for individuals with data for both Y179C and G396D

                                                                         **Model I\***^,^[a](#t2-fn3){ref-type="fn"}   **Model I**[b](#t2-fn4){ref-type="fn"}                                          
  ---------------------------------------------------- -------- -------- --------------------------------------------- ---------------------------------------- -------------- ------- --------------- -------
  *G396D*[c](#t2-fn5){ref-type="fn"}                                                                                                                                                                   
  *Whole sample*                                                                                                                                                                                       
    GG                                                 19 767   14 723   1.00                                                                                                                           
    GA                                                 292      210      1.04                                          0.87, 1.24                               0.70                                    
    AA                                                 31       0        23.09                                         3.15, 169.15                             0.002          46.93   2.87, 766.89    0.007
   ⩽*55 Years old*                                                                                                                                                                                     
    GG                                                 6269     5270     1.00                                                                                                                           
    GA                                                 88       77       0.96                                          0.71, 1.31                               0.80                                    
    AA                                                 13       0        10.93                                         1.43, 83.57                              0.02           22.70   1.35, 381.91    0.03
   \>*55 Years old*                                                                                                                                                                                    
    GG                                                 13 498   9453     1.00                                                                                                                           
    GA                                                 204      133      1.07                                          0.86, 1.34                               0.52                                    
    AA                                                 18       0        12.60                                         1.68, 94.37                              0.01           25.91   1.56, 430.03    0.02
   *Males*                                                                                                                                                                                             
    GG                                                 11 229   6460     1.00                                                                                                                           
    GA                                                 161      95       0.98                                          0.76, 1.26                               0.85                                    
    AA                                                 15       0        8.62                                          1.14, 65.25                              0.04           17.84   1.07, 298.11    0.04
   *Females*                                                                                                                                                                                           
    GG                                                 8528     8259     1.00                                                                                                                           
    GA                                                 131      115      1.10                                          0.86, 1.42                               0.45                                    
    AA                                                 16       0        15.49                                         2.05, 116.86                             0.008          31.96   1.92, 532.72    0.02
                                                                                                                                                                                                        
  *Y179C*[d](#t2-fn6){ref-type="fn"}                                                                                                                                                                   
   *Whole sample*                                                                                                                                                                                      
    AA                                                 19 767   14 723   1.00                                                                                                                           
    AG                                                 122      68       1.34                                          1.00, 1.80                               0.05                                    
   GG                                                  11       2        4.10                                          0.91, 18.48                              0.07           NA                       
   ⩽*55 Years old*                                                                                                                                                                                     
    AA                                                 6269     5270     1.00                                                                                                                           
    AG                                                 35       25       1.18                                          0.70, 1.97                               0.54                                    
    GG                                                 9        0        7.57                                          0.96, 59.74                              0.06           15.97   0.93, 274.491   0.06
   \>*55 Years old*                                                                                                                                                                                    
    AA                                                 13 498   9453     1.00                                                                                                                           
    AG                                                 87       43       1.42                                          0.98, 2.04                               0.06                                    
   GG                                                  2        2        0.70                                          0.10, 4.97                               0.72           NA                       
   *Males*                                                                                                                                                                                             
    AA                                                 11 229   6460     1.00                                                                                                                           
    AG                                                 68       23       1.70                                          1.06, 2.73                               0.03                                    
    GG                                                 8        0        4.60                                          0.58, 36.80                              0.15           9.78    0.56, 169.48    0.12
   *Females*                                                                                                                                                                                           
    AA                                                 8528     8259     1.00                                                                                                                           
    AG                                                 54       45       1.16                                          0.78, 1.73                               0.46                                    
    GG                                                 3        2        1.45                                          0.24, 8.70                               0.68           NA                       
                                                                                                                                                                                                        
  *Genotype*[e](#t2-fn7){ref-type="fn"}                                                                                                                                                                
   *Whole sample*                                                                                                                                                                                      
    WW                                                 19 767   14 723   1.00                                                                                                                           
    WM                                                 418      280      1.11                                          0.95, 1.29                               0.17                                    
    MM                                                 76       2        28.30                                         6.95, 115.26                             3.1 × 10^−6^   NA                       
    G396D AA                                           31       0        23.09                                         3.15, 169.15                             0.002          46.93   2.87, 766.89    0.007
    Y179C GG                                           11       2        4.10                                          0.91, 18.48                              0.07           NA                       
    Compound heterozygous[f](#t2-fn8){ref-type="fn"}   29       0        21.60                                         2.94, 158.58                             0.003          43.95   2.69, 719.26    0.008
                                                                                                                                                                                                        
   ⩽*55 Years old*                                                                                                                                                                                     
    WW                                                 6269     5270     1.00                                                                                                                           
    WM                                                 124      104      1.00                                          0.77, 1.30                               0.99                                    
    MM                                                 43       0        36.15                                         4.98, 262.57                             0.0004         73.14   4.50, 1188.3    0.003
    G396D AA                                           13       0        10.93                                         1.43, 83.57                              0.02           22.70   1.35, 381.91    0.03
    Y179C GG                                           9        0        7.57                                          0.96, 59.74                              0.06           15.97   0.93, 274.49    0.06
    Compound heterozygous                              17       0        14.29                                         1.90, 107.42                             0.01           29.42   1.77, 489.38    0.02
                                                                                                                                                                                                        
   \>*55 Years old*                                                                                                                                                                                    
    WW                                                 13 498   9453     1.00                                                                                                                           
    WM                                                 294      176      1.17                                          0.97, 1.41                               0.10                                    
    MM                                                 33       2        11.56                                         2.77, 48.17                              0.001          NA                       
    G396D AA                                           18       0        12.60                                         1.68, 94.37                              0.01           25.91   1.56, 430.03    0.02
    Y179C GG                                           2        2        0.70                                          0.10, 4.97                               0.72           NA                       
    Compound heterozygous                              12       0        8.40                                          1.09, 64.64                              0.04           17.51   1.04, 295.75    0.05
                                                                                                                                                                                                        
   *Males*                                                                                                                                                                                             
    WW                                                 11 229   6460     1.00                                                                                                                           
    WM                                                 232      119      1.12                                          0.90, 1.40                               0.31                                    
    MM                                                 36       0        20.71                                         2.84, 151.09                             0.003          42.00   2.58, 684.38    0.009
    G396D AA                                           15       0        8.62                                          1.14, 65.25                              0.04           17.84   1.07, 298.11    0.04
    Y179C GG                                           8        0        4.60                                          0.58, 36.80                              0.15           9.78    0.56, 169.48    0.12
    Compound heterozygous                              12       0        6.90                                          0.90, 53.10                              0.06           14.38   0.85, 242.96    0.06
                                                                                                                                                                                                        
   *Females*                                                                                                                                                                                           
    WW                                                 8528     8259     1.00                                                                                                                           
    WM                                                 186      161      1.12                                          0.90, 1.38                               0.30                                    
    MM                                                 40       2        19.37                                         4.68, 80.17                              4.3 × 10^−5^   NA                       
    G396D AA                                           16       0        15.49                                         2.05, 116.86                             0.008          31.96   1.92, 532.72    0.02
    Y179C GG                                           3        2        1.45                                          0.24, 8.70                               0.68           NA                       
    Compound heterozygous                              17       0        16.46                                         2.19, 123.70                             0.006          33.90   2.04, 563.74    0.01

Abbreviations: CI=confidence interval; MM=mutated/mutated; NA=not available; OR=odds ratio; WM=wild type/mutant; WW=wild type/wild type.

^\*^Crude analysis.

Estimated by adding one control with the variant genotype.

Estimated using the meta command of STATA and for mathematical reasons, cells with zero frequencies were assumed to be 0.5 (as defaulted by the meta command).

Analysis conducted only for the AA Y179C, that is, WW.

Analysis conducted only for the GG G396D, that is, WW.

Including subjects with data for both Y179C and G396D.

This category includes 29 G396D GA and Y179C AG cases; 5 cases with either G396D GA or Y179C AG and any other pathogenic *MUTYH* mutation were excluded.

###### Meta-analysis of studies[a](#t3-fn2){ref-type="fn"}

                                                  **Genotype (cases)**   **Genotype (controls)**   **WM *vs* WW**   **MM *vs* WW**                                  
  ----------------------------------------------- ---------------------- ------------------------- ---------------- ---------------- ----- --- -------------------- ----------------------
  [@bib9]                                         994                    5                         4                424              0     0   4.70 (0.26, 85.10)   3.84 (0.21, 71.51)
  [@bib16]                                        90                     2                         0                52               ---   0   1.16 (0.10, 13.06)   NA
  [@bib28]                                        432                    10                        2                309              4     0   1.79 (0.56, 5.75)    3.58 (0.17, 74.79)
  [@bib30]                                        432                    6                         0                466              3     0   2.16 (0.54, 8.68)    NA
  [@bib22]                                        549                    4                         2                911              7     0   0.95 (0.28, 3.25)    8.29 (0.40, 173.08)
  Tomlinson I (2006)[b](#t3-fn3){ref-type="fn"}   662                    15                        1                197              2     0   2.23 (0.51, 9.84)    0.89 (0.04, 22.04)
  [@bib19]                                        323                    9                         0                278              6     0   1.29 (0.45, 3.67)    NA
  [@bib6]                                         859                    11                        2                473              5     0   1.21 (0.42, 3.51)    2.75 (0.13, 57.49)
  Koessler T (2007)[c](#t3-fn4){ref-type="fn"}    2198                   37                        9                2204             42    0   0.88 (0.57, 1.38)    19.05 (1.11, 327.53)
  [@bib17]                                        999                    24                        1                1100             21    0   1.26 (0.70, 2.27)    3.30 (0.13, 81.18)
  [@bib3]                                         1089                   19                        8                912              22    0   0.72 (0.39, 1.34)    14.24 (0.82, 247.02)
  SOCCS (2008)[d](#t3-fn5){ref-type="fn"}         3429                   77                        16               2993             57    0   1.18 (0.83, 1.67)    28.80 (1.73, 480.32)
  [@bib2]                                         435                    2                         2                246              1     0   1.13 (0.10, 12.54)   2.83 (0.14, 59.19)
  [@bib5][e](#t3-fn6){ref-type="fn"}              3697                   87                        27               2758             43    1   1.51 (1.04, 2.18)    20.14 (2.74, 148.32)
  [@bib18][f](#t3-fn7){ref-type="fn"}             9043                   198                       27               4962             101   1   1.08 (0.84, 1.37)    14.82 (2.01, 109.06)
  *M--H pooled effect (fixed)*                    25231                  506                       101              18285            315   2   1.16 (1.00, 1.34)    10.80 (5.02, 23.21)
   *P*-value                                                                                                                                   0.05                 \<0.0005
                                                                                                                                                                     
  *Heterogeneity*                                                                                                                                                   
   *P*-value                                                                                                                                   0.82                 0.84
   *I*^2^ (95% CI)                                                                                                                             0 (0, 54)            0 (0, 60)

Abbreviations: CI=confidence interval; MM=mutated/mutated; NA=not available; OR=odds ratio; WM=wild type/mutant; WW=wild type/wild type.

This table presents the data as they were published. Two unpublished studies included.

Unpublished data obtained in 2006.

Unpublished data obtained in 2007.

Includes data from [@bib10], [@bib25] and unpublished data from the SOCCS study obtained in 2008.

Includes data from [@bib7].

Includes data from [@bib29] and [@bib12].

###### Meta-analysis of studies for the G396D genotypes[a](#t4-fn2){ref-type="fn"}

                                                  **G396D (cases)**   **G396D (controls)**   **GA *vs* GG**   **AA *vs* GG**                                         
  ----------------------------------------------- ------------------- ---------------------- ---------------- ---------------- ----- --- --------------------------- ----------------------
  [@bib9]                                         994                 4                      1                424              0     0   3.84 (0.21, 71.51)          1.28 (0.05, 31.50)
  [@bib16]                                        90                  2                      0                52               ---   0   Not enough data available   NA
  [@bib28]                                        432                 5                      0                309              2     0   1.79 (0.35, 9.28)           NA
  [@bib30]                                        432                 1                      0                466              1     0   1.08 (0.07, 17.30)          NA
  [@bib22]                                        549                 2                      0                911              5     0   0.66 (0.13, 3.43)           NA
  Tomlinson I (2006)[b](#t4-fn3){ref-type="fn"}   662                 9                      1                197              2     0   1.34 (0.29, 6.25)           0.89 (0.04, 22.04)
  [@bib19]                                        323                 9                      0                278              6     0   1.29 (0.45, 3.67)           NA
  [@bib6]                                         859                 8                      0                473              4     0   1.10 (0.33, 3.67)           NA
  Koessler T (2007)[c](#t4-fn4){ref-type="fn"}    2198                25                     2                2204             31    0   0.81 (0.48, 1.37)           5.01 (0.24, 104.49)
  [@bib17]                                        999                 21                     0                1100             16    0   1.45 (0.75, 2.79)           NA
  [@bib3]                                         1089                15                     1                912              20    0   0.63 (0.32, 1.23)           2.51 (0.10, 61.75)
  SOCCS (2008)[d](#t4-fn5){ref-type="fn"}         3429                56                     8                2993             42    0   1.16 (0.78, 1.74)           14.84 (0.86, 257.19)
  [@bib2]                                         435                 2                      1                246              0     0   2.83 (0.14, 59.19)          1.70 (0.07, 41.84)
  [@bib5][e](#t4-fn6){ref-type="fn"}              3697                63                     11               2758             32    0   1.47 (0.96, 2.25)           17.16 (1.01, 291.31)
  [@bib18][f](#t4-fn7){ref-type="fn"}             9043                128                    10               4962             75    0   0.94 (0.70, 1.25)           11.52 (0.68, 196.69)
  *M--H pooled effect (fixed)*                    25 231              350                    35               18 285           236   0   1.07 (0.90, 1.26)           6.47 (2.33, 17.97)
   *P*-value                                                                                                                             0.44                        \<0.0005
  *Heterogeneity*                                                                                                                                                    
   *P*-value                                                                                                                             0.74                        0.73
   *I*^2^ (95% CI)                                                                                                                       0 (0, 55)                   0 (0, 68)

Abbreviations: CI=confidence interval; MM=mutated/mutated; NA=not available; OR=odds ratio; WM=wild type/mutant; WW=wild type/wild type.

This table presents the data as they were published. Two unpublished studies included.

Unpublished data obtained in 2006.

Unpublished data obtained in 2007.

Includes data from [@bib10], [@bib25] and unpublished data from the SOCCS study obtained in 2008.

Includes data from [@bib7].

Includes data from [@bib29] and [@bib12].

###### Meta-analysis of studies for the Y179C genotypes[a](#t5-fn2){ref-type="fn"}

                                                  **Y179C (cases)**   **Y179C (controls)**   **AG *vs* AA**   **GG *vs* AA**                                         
  ----------------------------------------------- ------------------- ---------------------- ---------------- ---------------- ----- --- --------------------------- ---------------------
  [@bib9]                                         994                 1                      0                424              0     0   1.28 (0.05, 31.50)          NA
  [@bib16]                                        90                  0                      0                52               ---   0   Not enough data available   NA
  [@bib28]                                        432                 5                      1                309              2     0   1.79 (0.35, 9.28)           2.15 (0.09, 52.87)
  [@bib30]                                        432                 3                      0                466              2     0   1.62 (0.35, 9.28)           NA
  [@bib22]                                        549                 2                      0                911              2     0   1.66 (0.23, 11.81)          NA
  Tomlinson I (2006)[b](#t5-fn3){ref-type="fn"}   662                 6                      0                197              0     0   3.88 (0.22, 69.10)          NA
  [@bib19]                                        323                 0                      0                278              0     0   NA                          NA
  [@bib6]                                         859                 3                      0                473              1     0   1.65 (0.17, 15.93)          NA
  Koessler T (2007)[c](#t5-fn4){ref-type="fn"}    2198                12                     1                2204             11    0   1.09 (0.48, 2.48)           3.01 (0.12, 73.88)
  [@bib17]                                        999                 3                      0                1100             4     0   0.83 (0.18, 3.70)           NA
  [@bib3]                                         1089                4                      2                912              1     0   3.35 (0.37, 30.02)          4.19 (0.20, 87.34)
  SOCCS (2008)[d](#t5-fn5){ref-type="fn"}         3429                21                     3                2993             15    0   1.22 (0.63, 2.38)           6.11 (0.32, 118.34)
  [@bib2]                                         435                 0                      0                246              1     0   0.19 (0.01, 4.65)           NA
  [@bib5][e](#t5-fn6){ref-type="fn"}              3697                15                     5                2758             10    1   1.12 (0.50, 2.50)           3.73 (0.44, 31.95)
  [@bib18][f](#t5-fn7){ref-type="fn"}             9043                70                     4                4962             26    1   1.48 (0.94, 2.32)           2.20 (0.25, 19.64)
  *M-H pooled effect (fixed)*                     25 231              145                    16               18 285           75    2   1.34 (1.01, 1.77)           3.35 (1.14, 9.89)
   *P*-value                                                                                                                             0.04                        0.03
                                                                                                                                                                      
  *Heterogeneity*                                                                                                                                                    
   *P*-value                                                                                                                             0.98                        0.99
   *I*^2^ (95% CI)                                                                                                                       0 (0, 57)                   0 (0, 75)

Abbreviations: CI=confidence interval; MM=mutated/mutated; NA=not available; OR=odds ratio; WM=wild type/mutant; WW=wild type/wild type.

This table presents the data as they were published. Two unpublished studies included.

Unpublished data obtained in 2006.

Unpublished data obtained in 2007.

Includes data from [@bib10], [@bib25] and unpublished data from the SOCCS study obtained in 2008.

Includes data from [@bib7].

Includes data from [@bib29] and [@bib12].

[^1]: Present address: Infectious Disease Epidemiology Unit, London School of Hygiene and Tropical Medicine, Keppel Street, London, UK
